PMGC Capital Urges Alaunos Therapeutics to Accept Financing Offer from Leading Wall Street Bank

PMGC Capital LLC, a subsidiary of PMGC Holdings, is urging Alaunos Therapeutics to accept a term sheet from a leading Wall Street bank. The proposed financing represents a value-aligned opportunity for Alaunos and provides a clean and well-structured path forward for the company. PMGC Capital believes this is a timely and strategic opportunity for Alaunos to maximize long-term shareholder value.